Cancer

293 articles

Elevation Oncology - Antibody Drug Conjugate
Cancer

Elevation Oncology – Antibody Drug Conjugate

Joe Ferra, Interim CEO and CFO of Elevation Oncology discusses the company's development of an antibody-drug conjugate (ADC) that targets Claudin18.2, a...

Jul 14, 2023 3 min read